Compositions and methods for use in the treatment of cancer and other indications
TW202633634APending Publication Date: 2026-08-16THERAS INC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- TW114138668
- Authority / Receiving Office
- TW · TW
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2025-07-18
- Filing Date
- 2025-10-07
- Publication Date
- 2026-08-16
Smart Images
Figure TWG2TA001072708_001 
Figure TWG2TA001072708_002 
Figure TWG2TA001072708_003
Abstract
or a pharmaceutically acceptable salt thereof, in combination with a RAS inhibitor (e.g., KRAS inhibitor, such as BBO-8520 or BBO-11818), as described herein. Such methods may comprise the treatment of lung cancer, including non-small cell lung cancer (NSCLC), colorectal cancer, or pancreatic cancer.
Need to check novelty before this filing date? Find Prior Art